Hikma and Celltrion Forge Exclusive Licensing Deal to Enhance Biosimilar Access in MENA
Amman: Hikma Pharmaceuticals PLC, the multinational pharmaceutical group, has deepened its collaboration with global biopharmaceutical leader Celltrion Inc through a series of exclusive licensing agreements